The collected evidence is in, and drinking about eight cups of water per day is, in fact, good for you. So says a University of California San Francisco team who crunched the data from 18 randomized controlled trials. “For such a ubiquitous and simple intervention, the evidence hasn’t been clear and the benefits were not… read on > read on >
The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the risk of diabetes in obese prediabetic patients by more than 90% during a three-year period compared to placebo, trial results show. “These results show that type 2 diabetes may be prevented, even… read on > read on >
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid. However, the move would have to be approved by the new Trump administration. Right now, a law passed by Congress two decades ago prevents the Medicare and Medicaid from covering any… read on > read on >
The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs in people with or without diabetes. GLP-1s… read on > read on >
The “brain fog” of long COVID might be due to impaired lung function following a person’s infection, a new small-scale study says. Reduced gas exchange in the lungs – oxygen coming in, carbon dioxide going out — appears to be associated with brain fog in long COVID, researchers will report in Chicago at next week’s… read on > read on >
So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where decadent food will be served in abundance. Luckily, one expert from Baylor College of Medicine has tips on how to enjoy holiday fare… read on > read on >
.jpg)
How long Americans can expect to live varies dramatically — and the gap continues to widen. A new report says health inequalities have, in essence, created 10 Americas. These mutually exclusive populations are divided along familiar fault lines, including race, ethnicity, income and address. While life expectancy rose in nine of 10 Americas between 2000… read on > read on >
A daily dose of vitamin B3 reduced inflammation in the lungs of patients with COPD, Danish researchers report. “This is significant, because inflammation can lead to reduced lung function in these patients,” said researcher Morten Scheibye-Knudsen, of the University of Copenhagen. Patients with COPD — the full name of which is chronic obstructive pulmonary disease… read on > read on >
America’s kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows. GLP-1s like Ozempic, Wegovy, Mounjaro and Zepbound all work by making food less desirable, and it’s showing up in more food wasted at dinner tables, said a team led by Brian Roe, of… read on > read on >
A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand named Zepbound, included 731 patients with diastolic heart failure and obesity who were followed for two years. “This class of drugs continue to show benefits far beyond… read on > read on >
-300x200.jpg)
